Key result
Higher handgrip strength linked to ~0.09 mmHg lower pulse pressure per kg.
Why the study?
The cardiometabolic consequences of sarcopenic obesity remain poorly characterized in Latin America.
Does handgrip strength independently predict arterial stiffness and metabolic syndrome in older Mexican adults?
Cross-Sectional (n=2,087)
Does handgrip strength independently predict arterial stiffness and metabolic syndrome in older Mexican adults?
Mean Difference: -0.09 (95% CI -0.17–-0.01)
p-value: p=0.033
Handgrip strength is independently associated with lower pulse pressure in older Mexican adults, particularly women, suggesting that preserved muscle function may protect against arterial stiffening despite excess adiposity.
Background/Objectives: The cardiometabolic consequences of sarcopenic obesity (SO) remain poorly characterized in Latin America. We hypothesized that SO uniquely concentrates aortic stiffness, metabolic syndrome, and vitamin D deficiency in older Mexican adults, and that handgrip strength exhibits a dose–response relationship with cardiometabolic risk independent of adiposity. Methods: We conducted a cross-sectional analysis of 2087 adults ≥ 50 years from the Mexican Health and Aging Study (MHAS) 2012. Four phenotypes were defined using EWGSOP2 criteria: lean–fit, lean–sarcopenic, obese–non-sarcopenic, and obese–sarcopenic (BMI ≥ 30 kg/m2). Outcomes were pulse pressure (PP, aortic stiffness proxy), metabolic syndrome (modified IDF criteria), and serum 25(OH)D. Normality tests confirmed non-normal distribution (p < 0.001). Given heteroscedasticity (Breusch–Pagan p < 0.001), HC3 robust standard errors were used. Regression models were sex-adjusted and sex-stratified. Results: The sample showed high cardiometabolic burden: mean HbA1c 6.91% (35.3% ≥ 6.5%); metabolic syndrome 57.6%; mean PP 60.7 ± 17.9 mmHg; mean gait speed 0.708 m/s (70.4% slow). Phenotype distribution: lean–fit 12.3%; lean–sarcopenic 47.3%; obese–non-sarcopenic 8.7%; obese–sarcopenic 31.7%. In multivariable models, handgrip strength was an independent protective predictor of PP (beta = −0.09 per kg; 95% CI: −0.17 to −0.01; p = 0.033), with a sex-specific effect in women (beta = −0.13; p = 0.010). Conclusions: SO is highly prevalent in older Mexican adults and associates with an adverse cardiometabolic profile. Handgrip strength shows a protective dose–response association with cardiometabolic risk independent of adiposity, identifying muscle function as a candidate modifiable factor that warrants confirmation in longitudinal and interventional studies. The obese–non-sarcopenic phenotype exhibited the lowest PP, unveiling the sarcopenic obesity paradox: adiposity without muscle function loss does not promote arterial stiffening.
No takes yet. Share an insight, caveat, or question.
García-Carrillo et al. (2026) conducted a cross-sectional in Sarcopenic obesity and arterial stiffness (n=2,087). Handgrip strength vs. Lower handgrip strength was evaluated on Pulse pressure (surrogate marker of arterial stiffness) (beta = -0.09 per kg, 95% CI -0.17 to -0.01, p=0.033). Handgrip strength was an independent protective predictor of arterial stiffness, with each additional kilogram of strength associated with a 0.09 mmHg reduction in pulse pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: